Access cutting-edge cholangiocarcinoma treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access cholangiocarcinoma specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cholangiocarcinoma treatment provided free
This study is a Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician's Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR)-altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma
Sponsor: TransThera Sciences (Nanjing), Inc.
Check if you qualify for this cholangiocarcinoma clinical trial in Stanford, CA
If you're searching for cholangiocarcinoma treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cholangiocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.